WHO Backs 2 New Ebola Vaccines for Trial. 5,300+ Dead. Results Not Until 2027
WHO expert groups have recommended Oxford's ChAdOx1 BDBV and Moderna's mRNA-1469 for the DRC's Tumaini trial, the first active-outbreak test of vaccines targeting Bundibugyo Ebola.
Latin Times ·